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 Adipose tissue plays a key role in metabolic homeostasis. Adipose tissue functions 
are associated with various pathological conditions including obesity, insulin resistance, 
and other metabolic complications. Understanding the normal regulation of adipose 
tissue formation and homeostasis is imperative to understanding the pathologies 
associated with a decrease or increase in adipose tissue. We have undertaken an 
unbiased forward genetic screening to identify novel genes that affect lipid storage in 
zebrafish adipose tissue. We aimed to clone and characterize gene(s) responsible for 
sans suet (sns) mutant. We utilized next generation sequencing analysis and obtained 
four candidate variants that may have genetic linkage with sns mutation. The targeted 
sequencing revealed that the candidate variant on chromosome 5 (hdr gene) was 
heterozygous in sns mutant fish.  We hypothesize that the region near the hdr gene may 
have a stretch of a homozygous region that may be linked to sns phenotype.  In 
addition, our goal was to develop transgenic reporter and molecular tools to manipulate 
gene function for the study of adipose biology in zebrafish. We aimed to create a 
transgenic reporter line that expresses mCherry exclusively in adipocytes.  While testing 
the nuclease activity of Transcription Activator Like-Effector Nuclease (TALEN) in 
vivo, we found the inefficient introduction of double strand breaks in the predefined site 
of the genome.  This result necessitates redesigning the genome engineering nuclease 
for efficient double strand breakage for successful knock-in. 
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POSITIONAL CLONING AND MAPPING OF SAN SUET MUTATION 
 
1.1    Introduction 
 Lipid storage is an evolutionary conserved process that occurs from yeast to higher 
vertebrates. In yeast, lipids are stored as droplets composed surface monolayer of 
phospholipids that surround hydrophobic lipid cores (1). Nematodes such as 
Caenorhabiditis elegans (C. elegans) adults store lipids in gut granules and enterocyte 
lysosomes.  Drosophila consists of specialized fat bodies to store lipids (2). The 
vertebrates possess the specialized adipose tissues to store lipids in the body. The 
adipocyte functions extend beyond passive energy storage, in that they have endocrine 
secretory properties and provide mechanical protection to the body (3). White adipose 
tissue (WAT) is characterized by a large unilocular lipid droplet that stores the bulk of 
neutral lipids. WAT regulates various processes such as insulin sensitivity, lipid 
metabolism, and satiety (4). 
 The rapid rise in prevalence of obesity and its associated complications such as 
obesity, insulin resistance, diabetes, and cardiovascular diseases have posed a major 
financial burden to tackle and prevent these conditions worldwide (4). The deranged lipid 
storage in adipose tissue is associated with a variety of these clinical conditions.  




and lipid storage in vivo and the pathologies associated with it.  
  
1.1.1 Mechanism of adipogenesis 
 Adipocytes are derived from pluripotent mesenchymal stem cells that reside in 
vascular stroma of adipose tissues. Under appropriate signal, these stem cells are 
stimulated and committed to form pre-adipocyte lineage. These pre-adipocytes undergo 
mitotic clonal expansion and differentiation to mature adipocytes (5). The developmental 
programs, transcriptional cascades, and basic proteins that regulate adipocyte 
development, fat synthesis, storage, and lipolysis are functionally conserved (6). 
  Multiple signaling pathways have been implicated in normal adipogenesis, including 
the bone morphogenetic protein (BMPs), transforming growth factor- beta (TGF-β), 
insulin like growth factor 1 (IGF-1), fibroblast growth factor (FGF), 
wingless/integration1 (Wnt), and hedgehog (HH) signaling pathways. Genetic alterations 
of these signaling pathways have shown to influence adipose tissue depots (3). During the 
transformation of mature adipocytes, pre-adipocytes undergo marked changes in 
morphology and gene expression. Peroxisome proliferator-activated receptor gamma 
(PPAR-γ) is the master transcriptional factor that is necessary and sufficient to drive 
adipogenesis (7). PPAR-γ activates its targets in pre-adipocytes and adipocytes, including 
CCAAT/enhancer-binding protein alpha (C/EBP-α). C/EBP-α, in turn, activates PPAR-γ 
via a positive feedback loop. PPAR-γ and C/EBP-α also activate expression of genes in 
lipid metabolism, glucose transport, fatty acid handling, and secretory factors such as 





1.1.2 Lipid storage and mobilization in adipose tissue 
 Adipose tissue is the major site for storage of surplus fuels in the form of triglycerides 
(neutral lipid) in the body. However, when the fuels are scarce, adipose tissue undergo 
breakdown of stored triglycerides into fatty acids and glycerol. The fatty acids enter the 
bloodstream and mobilize to various organs for oxidation. Glycerol is transported into the 
liver, where it serves as gluconeogenic substrate. The lipid synthesis and mobilization 
processes in adipose tissues are regulated by different hormones and nutrients. Insulin 
enhances uptake and storage of lipids in adipose tissues. In response to adrenergic 
signals, phosphorylation and activation hormone sensitive lipase lead to hydrolysis of 
stored triglycerides into free fatty acid and glycerol in adipose tissue (Fig. 1.1).  
 
 
Figure 1.1 Lipid Metabolism in adipose tissue. a) Uptake of fatty acids from circulation 
and conversion into acyl CoA. b) Uptake of glucose and conversion to acetyl coA, 
precursor for fatty acids, c) Regulation of triglyceride metabolism by insulin and 
adrenergic signals, d) synthesis and incorporation of triglycerides into lipid droplets, e) 
breakdown of lipids and release of fatty acid and glycerol to circulation ((9)). 
Abbreviations: triglycerides (TG), very low density lipoprotein (VLDL), free fatty acids 
(FFA), Acyl CoA synthetase (ACS), insulin receptor (IR), insulin receptor substrate 
(IRS), phosphoinositide-3-kinase (PI3K), adenylate cyclase (AC), cyclic adenosine 




 The dietary and endogenous lipids are transported as lipoproteins in the blood stream. 
Chylomicrons and very low density lipoprotein (VLDL) consist of a large proportion of 
triglycerides. The lipoprotein lipase facilitates the import of fatty acid import into adipose 
tissues. The lipoprotein lipase hydrolyzes triglycerides into fatty acid and glycerol. The 
fatty acid are taken into adipocytes and converted into fatty acyl CoA and ultimately into 
triglycerides that are incorporated into lipid droplets. The glucose can be metabolized 
into pyruvate, which can be further oxidized to acetyl CoA. Acetyl CoA is the precursor 
for de novo fatty acid synthesis and triglyceride synthesis (9). 
 
1.1.3 Influence of fatty acid metabolism in adiposity 
 Genome-wide and targeted screens have been performed in yeast, worms, flies, 
mice, and human cell lines to identify the genes that influence degree of adiposity (10–
14).  These studies have contributed to our current understanding of adipose biology and 
lipid metabolism. Studies have shown that defects in processes such as fatty acid 
synthesis, desaturation, elongation, or fatty acid oxidation result in decreased lipogenesis, 
decreased lipid storage, increased fatty acid oxidation, and resistance to diet induced 
insulin resistance (15–17). Mice lacking acetyl CoA carboxylase 2, an enzyme involved 
in de novo fatty acid synthesis, showed increased fatty acid oxidation, energy 
expenditure, and decreased adiposity (15). Similarly, mice lacking ELOVL2 are reported 
to have constrained lipid storage. These mice have normal food intake but increased fatty 
acid oxidation (16).  
Impaired lipid uptake from the intestine may influence adiposity. The zebrafish 




characterization of ffr revealed the altered vesicular transport resulting in impaired lipid 
absorption in the enterocytes (18).  
 
1.1.4 Influence of feeding regulation in adiposity 
 The hypothalamus-adipose axis plays a key role in controlling food intake and 
appetite. The arcuate neurons release orixgenic neuropeptides such as neuropeptide Y 
(NPY) and Agouti related protein (AgRP), which increase the food intake (19). The 
anorexigenic hormone proopiomelanocorticotrophin (POMC) decreases the food intake. 
Leptin released from adipose tissue binds to the leptin receptor in the arcuate nucleus, 
resulting in increased expression of POMC and decreased food intake. Impaired genes 
that affect hypothalamus-adipose control of feeding alter energy intake and adiposity in 
animals (19–22). 
 
 1.1.5 Lipodystrophy genes and adiposity 
 Lipodystrophies are a group of rare disorders that are marked by selective loss of 
adipose depots. Lipodystrophies predispose patients to metabolic complications such as 
insulin resistance, hypertriglyceridemia, and hepatic steatosis (23). Lipodystrophies can 
be classified as a genetic and acquired form. Disruption of key genes involved in 
adipogenesis, lipid uptake, synthesis, and lipid droplet formation lead to the genetic form 
of lipodystrophies in humans. The genetic form of lipodystrophy can be classified into 
familial partial lipodystrophy (FPLD) and congenital partial lipodystrophy (CGL).  
Mutation in genes such as PPAR-γ, laminA/C (LMNA), AKT2, and perilipin (PLIN1) are 




(AGPAT2), Berardinell—Seip congenital lipodystrophy 2 (BCSL2), Caveolin 1 (CAV1), 
and Polymerase I and transcript release factor (PTRF) are reported in CGL (23). These 
evidences indicate that lipodystrophies are a heterogeneous group of disorders. The 
underlying mechanism of disease depends on the type of gene that is mutated, which adds 
complexity to designing targeted treatments (23). 
  
1.1.6 Zebrafish as a model to study lipid metabolism  
 Zebrafish are an established model for studying vertebrate development and 
organogenesis (24). Forward genetics in zebrafish provided meaningful insight into these 
processes (25). The development of a transgenic reporter and genetic tools offered 
zebrafish as a tractable system to perform large genetic screens and chemical screens 
(25).  Our laboratory focuses on lipid metabolism and abnormal lipid storage using a 
novel zebrafish model system. The inherent ability of zebrafish to develop obesity and 
atherosclerosis on high calorie diets, the presence of cholesterol ester transfer proteins 
(CETP) ortholog, and the presence of lipoprotein abundance similar to humans highlights 
the zebrafish (Danio rerio) as an attractive model to study lipid metabolism and 
associated disorders (26).  
 
1.1.7 Adipogenesis in zebrafish  
 Adipogenesis in zebrafish occurs after 8 days postfertilization (dpf). Pancreatic and 
visceral white adipose tissue are seen at approximately 8 to 10 dpf. Developmental timing 
of adipose tissue is asynchronous in zebrafish (27, 28).  Adipogenesis in zebrafish occurs 




semitransparent zebrafish larvae provide unique opportunity to study ontogeny of 
adipogenesis. WAT size in zebrafish is responsive to diet, starvation, and chemicals (27), 
(29). Zebrafish WATs also expresses adipocyte-specific genes (fabp11a, cfd, and 
adipoq), and they are functionally conserved to higher vertebrates (27, 28). This evidence 
supports the notion that zebrafish are a simple vertebrate system to study adipose biology. 
 
1.1.8 Metamorphosis in zebrafish 
 Metamorphosis is an abrupt postembryonic transformation of larvae to juvenile fish. 
Thyroid hormones trigger the metamorphosis via binding to the thyroid receptor (TR) 
protein. In zebrafish, the release of thyroid hormone occurs in a pulsatile manner. 
Thyroxine (T3), the active form of thyroid hormone, rises at 4 to 5 dpf and peaks at 10 
dpf. A second pulse begins at 14 dpf, peaks at 21 dpf, and starts declining after 
approximately 29 dpf (30). Thyroid hormone binding to TR triggers metamorphosis and 
directly regulates a few subsets of early response genes that in turn activate large 
secondary target genes in different organs (31). A variety of larval traits (fins, skins, 
melanophores, digestive system, and sensory system) are remodeled in a coordinated 
manner to generate adult zebrafish (32). The process involves tissue resorption, 
patterning, and redistribution. Studies in Drosophila showed that fat bodies (analogous to 
adipose tissues of vertebrate) undergo extensive redistribution, remodeling, apoptosis, 
and regeneration during metamorphosis (33). It is not known whether metamorphosis 






1.1.9 Forward genetic screen and genetic mapping 
 Forward genetic approaches seek to identify genes involved in the biological pathway 
or process through screening the particular displayed phenotype in mutagenized animals. 
N-ethyl-N-Nitrosourea (ENU) is a chemical mutagen that is standard choice for random 
mutagenesis. ENU is an alkylating agent that can achieve high random mutagenesis in 
zebrafish premeiotic germ cells.  The subsequent mapping of the allele within the genome 
reveals genes that are associated with the observed biological process. Various markers 
such as simple sequence length polymorphisms (SSLPs) and single nucleotide 
polymorphisms (SNPs) have been previously used to establish linkage (34). Mapping is 
based on the probability of recombination events occurring in a diploid genome during 
meiosis. A marker that is tightly linked to the mutation will segregate with the phenotype. 
In contrast, unlinked markers will segregate independently of the trait. Alternatively, 
genome sequencing technology has emerged as a robust method for positional cloning. 
Genome sequencing technologies have been applied to find linkage in different model 
organisms, including zebrafish (35–41).   
 
1.2    Materials and Methods 
1.2.1 ENU mutagenesis and recovery of mutants 
 The standard ENU mutagenesis was performed as previously described (42). The 









Figure 1.2 Mating scheme for forward screen and identification of phenotypes. 
Mutagenized males were outcrossed with wildtypes (Tu strain) to obtain F1 and F2 
generations. The F2s were in-crossed and screened for lack of adipose tissue mass. 
 
1.2.2 Breeding strategy for map cross 
 We identified the heterozygous fish from the F2 family that inherited the phenotype 
(lack of adipose tissue) in an autosomal recessive pattern (3:1). For positional cloning, we 
outcrossed these F2 to wildtype AB strain. We further screened and identified the 
heterozygous carrier pair that consistently inherited the mutation in autosomal recessive 





1.2.3    Nile red staining 
The Nile red (NR) staining was performed on live 18 dpf larvae.  A 500 µg/ml 
stock NR solution was prepared in acetone. Just before use, the working solution was 
obtained by 1/100 dilution of stock in fish water. Live larvae were then exposed to a NR 
working solution in the dark for 30 min at 28 oC till the NR adipocyte stain saturated. The 
larvae were then rinsed twice with fish water for 5 minutes, anaesthetized in 0.4% 
tricaine (w/v) pH 7.1, and observed under a fluorescence microscope (29).   
 
1.2.4 Extraction of DNA from zebrafish larvae 
 The 18-dpf  larvae were treatment with cell lysis buffer (10 mM Tris-HCL),  [pH 
8.0], 10 mM NaCl, 0.5% NP-40, and Proteinase K) for 3 hours for complete digestion of 
the larvae. The lysate were centrifuged, and supernatant DNA was used for PCR analysis. 
 
1.2.5 Analysis of ‘z’ markers 
 We ordered the primers sequences for selected ‘z’ markers that are available in the 
Ensembl database for zebrafish (http://uswest.ensembl.org/Danio_rerio). We amplified 
the genome DNA using these primers. The standard PCR was performed using the 
GoTaq Flexi DNA Polymerase kit (Promega). The PCR products were run on 4% agarose 
gel, and products from mutant pools, wildtype pools, and parents were compared. 
 
1.2.6 Whole genome sequencing 
 Parent fish heterozygous for the sns mutation in the AB strain were in-crossed to 




18-dpf larvae scored for lack of lipid stains in adipose tissue. DNA was extracted from 
these larvae using DNeasy blood and tissue kit (Qiagen Cat. 69504).  We pooled DNA 
from 43 larvae and processed for whole genome sequencing (WGS). Whole genomes 
from pooled DNA samples were sequenced by Illumina HiSeq2000 at the Huntsman 
Cancer Institute sequencing core, Utah. The process involved the fragmentation of 
genomic DNA into a library of small segments, PCR amplification, and high throughput 
sequencing.   
 
1.2.7 Whole exome sequencing 
 We obtained DNA from larvae from the mutant larvae and WT sibling. For sorting, 
we bred the heterozygotes fish in AB strain, and the larvae were stained with NR 
staining. NR staining allowed live scoring of wildtype and mutant fish. Furthermore, it 
circumvented paraformaldehyde treatment, which fragments the genomic DNA and 
lowers the genomic DNA yield.  We pooled the DNA from the 13 mutant larvae and sent 
for Hi-Seq2000 Illumina sequencing to the commercial vendor Optogenetics. In parallel, 
we also sequenced pooled DNA from 15 WT siblings. Whole exome sequencing (WES) 
is a method that allows a rapid identification of protein coding mutation including 
missense, nonsense, splice site, and small deletion/insertion mutations. The process 
involved enrichment of exons from genomic DNA followed by high throughput 







1.2.8 Sanger sequencing of candidate SNPs  
 We amplified the genome DNA using the primers that amplified the genomic region 
of DNA that flanks the candidate regions. The primers were designed using an Ape-A 
plasmid editor. The primers used for amplifying candidate variant on Chr1 
(ENSDARG00000052899) were forward 5’-gacaaatcaagagcacacacact-3’ and reverse 5’-
ctggcgtttcccatgttctt-3’. The primers used for amplifying candidate variant on Chr5 
(ENSDARG00000004392) were forward 5’-cttcataataccctcacctctaccct-3’ and reverse 5’-
ccagcagggcagtttagaca-3’. The primers used for amplifying candidate variant on Chr18 
(ENSDARG00000040582) were forward 5’-aaagaagaggcccaagaaagacaat-3’and  reverse  
5’-ctggcgtttcccatgttctttga-3’. The primers used for amplifying candidate variant on Chr24 
(ENSDARG00000062087) were forward 5’-gaggaggatggacagtcggaa-3’ and reverse       
5’-tgtcacttgtatttccctctcttgt -3’. The standard PCR was performed using GoTaq Flexi DNA 
Polymerase kit (Promega). Sanger sequencing was performed on the PCR purified 
amplicons.  
 
1.3    Results 
 We mutagenized zebrafish and screened offspring for the absence of stainable lipids 
in adipose tissue to find gene(s) that affect lipid storage in adipose tissue. A conventional, 
recessive, third generation (F3) mutagenesis screen was conducted. Male Tüebingen(Tü) 
fish were mutagenized with ethylnitrosourea (ENU). Members of individual F2 families 
were incrossed, and their progeny were stained with ORO (24, 26). At 18-dpf, we stained 
and screened the zebrafish for reduced adipocyte lipid mass following a recessive 
inheritance pattern (Fig. 1.3). We have identified one mutant that  follows this phenotypic 





Figure 1.3 Oil Red O staining to visualize neutral lipid droplets at 18 dpf.  (upper panel: 
wild type sibling and lower panel: sans suet) 
 
1.3.1 Genetic mapping of sns mutation by SSLP markers 
To identify the gene responsible for the sns mutation, our immediate goal was to map 
the sns mutation. To that end, our laboratory has employed traditional positional cloning 
techniques. Initially, our laboratory has used approximately 300 SSLP ‘z’ markers to find 
the genetic linkage (38), but we did not obtain linkage between the sns mutation and 
SSLP markers 
 
1.3.2 Genetic mapping of sns mutation by WGS 
 The conventional mapping strategies utilize a predefined set of markers within pooled 
genome of mutants to derive the genomic regions that are linked with the mutant 
phenotype.  Many markers are not polymorphic, in particular crosses or genetic 




(NGS) has increased the ability to map and identify mutation. In addition to mapping of 
the linkage region, NGS also provides sequence information within the linked interval. 
This enables the researcher to identify candidate mutations within the linked interval 
(38). We performed whole genome sequencing (WGS) on the sns-/- mutant larvae pool. 
We used a publicly available scheme (Galaxy Cloudmap) for variant discovery mapping 
(43).  The analysis of WGS involved the alignment of sequenced short reads to reference 
genome (Zv9) using the Burrow-Wheeler aligner (BWA) (44). This program allowed the 
researcher to efficiently align short sequence reads against a larger reference sequence, 
allowing identification of mismatches and gaps. The identification of variants was 
performed using the genome analysis toolkit (GATK) (45).  We hypothesize that 
genomic regions that are linked to the causal mutation will have low recombination. 
Thus, the region will have a stretch of pure parental sequences and be devoid of mapping 
strain sequences (43).  
 Based on the scatter plot we obtained from variant discovery mapping, we predicted 
the linkage group as shown in Fig. 1.4. To validate that true linkage group versus chance, 
we selected the ‘z’ markers that covered these genomic regions. We determined the SSLP 
on wildtype pool, mutant pool, and heterozygous parents. We screened SSLP markers 
(z4273, z4188, z1146, z8450) that covered 25Mb to 35Mb of chromosome 12. Similarly, 
we screened SSLP markers (z9488, z40230, z9189, z40745, z7070, G40006, G41815) 
that covered from 27 to 35 Mb of chromosome 15 and (z22659, z8809, z21170, z8976, 
z7158, z10758, z21401, z4304) that covered 20 to 31 MB of chromosome 20. The PCR 







Figure 1.4 Galaxy Cloudmap scatter plot.  The scatter plot represents the ratio of the 
number of reads of reference strain to the number of reads of (mutant) parental strain 
plotted against the chromosomal region (Mb). The linear regression line represents the 





1.3.3 Genetic mapping of sns mutation by WES 
 WES is now used to isolate mutations in humans and other model system (46, 47). 
Recently, the WES based methodology is described for the mapping and rapid isolation 
of mutations recovered from forward genetics (48). WES technology for mapping has 
proved robust with identification of missense, nonsense, and splice-site mutations. Exon 
enrichment, high coverage sequencing technology, and publicly available analysis 
software made WES a feasible alternative for mapping and identification of mutations in 
zebrafish. The SNP variant in zebrafish is not completely characterized compared to 
other model organisms.  The sequencing of the pool of unaffected larvae is required to 
identify the complete spectrum of informative variant in zebrafish (38).  Thus, we utilized 
robust WES to sequence whole exomes from pools of sns-/- mutants and WT siblings.  
Analysis of NGS data with SNP track has been previously used to find the linkage 
and candidate mutation (38). We applied a similar approach to analyze WES in our 
mutant pool and WT sibling pools.  We did not obtain the peak at single chromosomal 
region suggestive of linkage as anticipated. In contrast, we found multiple peaks at 
various chromosomal regions (Fig. 1.5). Since SSLP markers were not informative in 
previous attempts to establish the linkage, we attempted to establish the genetic linkage 
using variants that are obtained in both WGS and WES. To further investigate variant and 
determine candidate linkage region, we established the following criteria: a) variant must 
be homozygous in both WES and WGS, b) variant must have depth of coverage of at 
least 5 in whole genome sequence data and whole exome sequencing, c) variant must 
have human ortholog, and d) variant must induce a nonsynonymous mutation. Based on 













Figure 1.5 Graph represents for variants in WES.  The peaks represent arbitrary score for 
variants in the mutant pool compared against WT sibling pools. The peak density and 























regions.  The candidates region obtained are shown in Table 1.1. 
 
1.3.4 Targeted sequencing of candidate variants 
We designed the primer that amplifies the region and variant position mentioned in 
Table 1.1. We performed Sanger sequencing of these four different SNPs to determine if 
any of these regions are linked. We hypothesized that the linked region should be 
homozygous in mutant pool but heterozygous in WT pool.  The candidate SNPs on Chr1, 
Chr18, and Chr24 were homozygous background mutations that were found in both 
mutant pool and wildtype pool. The variant in hdr gene in Chr5 was heterozygous (G&A) 
in mutant pool (Fig. 1.6). 
 
1.4    Discussion 
Lipid storage in adipose tissues is affected by multiple factors. The characterization 
of sns mutant is crucial to understanding the phenotype. We hypothesize different 
scenarios that can result in a lack of stainable lipids in adipose tissue. First, the sns 
mutation may be linked to lipodystrophy where WAT lipid storage is altered due to 
decreased lipid uptake, synthesis, or droplet formation. This results in metabolic 
complications such as hepatic steatosis, hypertryglyceridemia, and insulin resistance (23). 
Second, the sns mutation may be linked to processes such as fatty acid synthesis, 
desaturation, or elongation or fatty acid oxidation. A defect in these processes result in 
decreased lipogenesis, decreased lipid storage, increased fatty acid oxidation, and 
resistant to diet induced insulin resistance (15–17). Third, the sns mutation may be 


































1 41134904  ENSDARG00000052899 Uncharacterized ENSG00000133574 GAC/GTC  
5 29051561  ENSDARG00000004392 Hdr ENSG00000104689 GGG/AGG  
18 32379671  ENSDARG00000040582 C18H3orf33 ENSG00000174928 CGG/TGG  











Figure 1.6 Alignment of PCR sequences of WT sibling pool and Mutant pool of sns 





(31, 49, 50). Finally, the sns mutation may be associated with defect in uptake of lipids in 
intestine or altered feeding behavior (18–22). The characterization of mutant phenotype 
could shed light on processes responsible for the phenotype. 
 We have used SSLP markers and next generation sequence analysis to determine the 
linkage of sns mutation. We have performed targeted SSLP marker analysis and SNP 
analysis in the regions that are derived from NGS approaches. We observed that variant 
at the hdr gene at chromosome 5 is heterozygous in mutant pool. The whole genome 
sequencing (Fig. 1.4) and whole exome sequencing analysis (Fig. 1.5) suggested that the 
region near 30 Mb of Chr5 regions have differences in the variant distribution compared 
to reference genome and WT sibling. Although the variant on the hdr gene is 
heterozygous, the region near these may have a stretch of a homozygous region that is 
suggestive of linkage. We only tested the nonsynonymous coding locus, but the variant 
may lie in the regulatory regions that were not considered during analysis. The sns 
mutation could be due to copy number variants. The bioinformatic software, such as 
EXCAVATOR, has been devised to detect the copy number variant from whole exome 
sequencing data (51).  
 Zebrafish are not a completely inbred model, and some background SNPs haplotypes 
are shared between different strains. The chemical mutagenesis was performed on Tu 
strain that have high structural background variants (52). These background mutations 
may have hindered the genetic mapping with both SSLP markers and NGS approaches. 
In these cases, diluting the Tu strain by breeding the heterozygous sns mutant pair to 
other WT strains may provide informative polymorphic markers and successful genetic 




heterozygous pairs and progeny from this outcross should be used for future mapping. 
Furthermore, prescreening and selection of informative polymorphic markers in mapping 
and mutant background strain could increase the linkage mapping efficiency. The next 
generation sequencing technology may be utilized for rapid and robust genetic mapping.  
 Other possibilities may be regions that are not completely covered during high 
throughput sequencing or low quality assembly of reference genome. In these cases, 
visualizing alignment of sequence in that particular region, Sanger sequencing on the low 
coverage region and virtual chromosome walking with BACs should be employed (53).  
The sequencing reads may be misaligned and duplicated during genome sequence 
analysis. In a previous study, the bioinformatic approach to remove the duplicated 
assembly of the reference genome has been shown to improve the linkage mapping (38). 
Alternately, linkage mapping is hindered when the phenotypic overlap between wildtype 
and mutant results in erroneous scoring of wildtype as a mutant. To determine true 
homozygous mutants, the mutant pools are being bred to examine the phenotypic ratio in 
progeny. The mutants that have the expected Mendelian phenotype ratio may be used for 








DEVELOP TRANSGENIC TOOLS TO STUDY  
ADIPOGENESIS 
 
2.1    Introduction 
 Previous studies have elegantly determined that adipose tissues are composed of 
precursor cells, adipocytes, and other cell types (6). It has now been revealed that new 
adipocytes are formed constantly to maintain the adipose tissue in human adults (54). The 
acute exposure to calorie excess results in increased adipocyte size. In contrast, the 
chronic high fat diet results in increased adipose size and number. It has been 
hypothesized that the adipocytes undergo hypertrophy to a threshold. After that, the 
precursor cells are recruited and committed to form new adipocytes (54, 55). The 
molecular basis for this regulation of adipose tissue dynamics is not fully understood. It is 
debatable whether the new adipose tissue is formed to compensate the metabolic 
demands in calorie excess. Thus, understanding adipogenesis in various nutritional states 
is vital to appreciate its importance. Our goal is to develop molecular tools in zebrafish to 
study adipogenesis. The study of adipose biology in zebrafish suffers from a lack of tools 
to visualize and genetically manipulate adipocytes. We aimed to develop a transgenic 
reporter line that specifically labels adipocytes in zebrafish. Fluorescently labeling 




nutrients in both larval and adult stages.  With the transgenic reporter tools, we can 
interrogate how adipogenesis is influenced by genetic, nutritional, and chemical factors. 
The transgenic reporter fish will allow us to monitor cell size and cell number in vivo 
fluorescence imaging. A previous study has shown that zebrafish are amenable for 
exploring chemical modulators of adipose tissue metabolism (29). In the long term, we 
will also a use a transgenic reporter to perform large genetic and chemical screens to find 
novel genes and pathways that modulate adipose tissue metabolism. Utilizing these tools, 
we may advance our understanding of adipose tissues and related disorders that may 
impact future therapeutic approaches and potential therapy.  
 
2.1.1 Meganucleases and transposases mediated transgenesis 
 Over the past decade, Isce-I meganuclease and Tol2 transposase mediated 
transgenesis has been developed to allow efficient integration into a host genome and 
transmission to successive generations. These technologies have been used to drive  a 
whole body or tissue specific expression of reporters, genes that have allowed dissection 
of gene function at the molecular level and in a tissue specific manner (56, 57). Utilizing 
these two technologies, various groups have successfully integrated a bacterial artificial 
chromosome (BAC) as well as a short functional promoter fraction to create transgenic 
reporters. BACs encompass approximately 350 kb fragments including regulatory 
sequences and can be re-engineered and modified to contain reporters of choice to create 
stable transgenic animals (57, 58). There are daunting technical challenges in dealing 
with large BAC engineering and genomic integration. To circumvent these potential 




specific reporter and transgenic tools. Placing these functional promoters at the 5’ end of 
a reporter cassette fully recapitulates the endogenous expression pattern.  The caveat is 
identification of a minimal promoter fragment that encompasses the essential regulatory 
elements to mimic endogenous expression (59). Despite numerous efforts, we and others 
have been unable to identify a short functional promoter that drives tissue specific 
expression in adipocytes. Our laboratory has tried 5’ upstream DNA fragment of adipoq, 
plin2, and the full mouse ap2 promoter to drive expression of transgenes without success.  
 
2.1.2 TALEN based genome engineering tools 
 Genome engineering is the modification of the genome at a precise and predefined 
locus. In recent years, the emergence of novel genome engineering tools such as zinc 
finger nuclease (ZFN), Trascriptional Activator Like Effector Nuclease (TALEN), and 
clustered regularly interspaced short palindromic repeats (CRISPR) has allowed efficient 
and effective transgenesis in an unprecedented manner. Studies have reported that gene 
targeting through homologous recombination events are enhanced by several orders of 
magnitude using nucleases (ZFN, TALEN) (60). The double strand break created by 
these nucleases are efficiently repaired by error prone nonhomologous end joining 
(NHEJ), resulting in gene disruption. In the presence of homologous donor DNA NHEJ, 
and homology directed repair (HDR) result in integration of donor DNA into the host 
genome, resulting in targeted gene modification (61). 
 TALEN is a genome engineering nuclease created by fusion of a Transcription 
Activator Like Effector (TALE) and the type II FokI restriction enzyme (60). TALE is a 




recognition elements are a series of tandem repeats (34 amino acids for TALEs). The 
TALE repeat recognizes a single base pair of DNA. The repeats are highly conserved 
except for two amino acids at positions 12 and 13. These variable diresidues (RVDs) 
appear to specify the base pairing (62, 63). The DNA binding motif can be modified and 
designed to bind the target DNA of interest. Asn-Asn, Asn-Ile, His-Asp, and Asn-Gly are 
four different RVD modules that recognized guanine, adenine, cytosine, and thymine, 
respectively (60).  Upon binding two TALENs to predefined sites of DNA, formation of 
the FokI subdomain dimer cleaves the target DNA in the genome (Fig. 2.1). The TALEN 
exhibits significantly reduced off-target effects and cytotoxicities (64). TALENs have 
been used to create null mutations and conditional alleles in zebrafish, Drosophila, and 
mice (64–66).  
 TALEN has proven efficient to introduce locus-specific DNA replacement in both 
somatic and germline tissues (60). Recently, studies have shown that both single-stranded 
oligonucleotides and double-stranded eGFP cassettes can be inserted into a predefined 
region in the zebrafish genome through HDR, but the precise HDR was less frequent than 
error prone NHEJ-mediated integration. In these studies, donor DNA was flanked by the 
homologous arm to guide proper integration of donor DNA into the zebrafish genome  
(67).  
 We are employing TALEN-based genome engineering technology to create 
transgenic zebrafish that express mCherry-CAAX exclusively in adipocyte. Because of 
the adipocyte-specific expression of fabp11a, we aimed to construct a reporter that drives 
the expression of mCherry-CAAX under the endogenous fabp11a promoter.   We are 





Figure 2.1 Representation of the TALEN binding to target DNA. The 34 amino acid 
tandem repeats bind to target DNA resulting in dimerization of FokI endonuclease. The 
dimerization of FokI introduces the double strand break in the spacer region of the target 
DNA. 
 
fabp11a gene and mCherry-CAAX in a bicistronic manner. The principle and strategy is 
outlined in Fig. 2.1  
 
2.2    Materials and Methods 
2.2.1 TALEN design and assembly 
 The TALEN was designed by the Mutation Generation and Analysis Core, University 
of Utah. For designing TALEN, the exon 4 sequence of the fabp11a gene was screened 
for potential target sites using a TALEN targeter program                                                       
(https://tale-nt.cac.cornell.edu/node/add/talen). The pCS2-fab11a-TALENL and pCS2 







2.2.2 Designing the reporter construct 
 The reporter construct sequences were designed as shown in Fig. 2.2. We obtained 
the mCherry-CAAX construct flanked by the homologous arm from gene synthesis, 
Genewiz, NJ. 
 
2.2.3 Synthesis of TALEN mRNA and injections 
For in vitro mRNA synthesis, the TALEN plasmids were linearized using NotI 
restriction enzymes. The in vitro TALEN 5’capped mRNA was synthesized by using the 
mMessage mMachine SP6 kit. For in vitro transcription, 10 uL of 2X NTP/CAP, 2 ul of 
10X Reaction buffer, 1 ug of linearized plasmid, and 2 uM of enzyme mix was added and 
incubated for 2 hours. After 2 hours, 1uL of Turbo DNase was added to hydrolyze 
linearized plasmid. mRNA was purified using RNeasy Qiagen kit. About 100 embryos 
incubated for 2 hours. After 2 hours, 1uL of Turbo DNase was added to hydrolyze 
linearized plasmid. mRNA was purified using RNeasy Qiagen kit. About 100 embryos 
were co-injected with TALEN mRNA and 100 pg of mCherry construct. We have 
injected 100, 200, and 500 pg of TALEN mRNA to determine the optimal cleavage 
activity of TALEN.  
 
2.2.4 High resolution melting analysis 
 The TALEN induced mutation was detected using high resolution melting analysis as 
previously described (67). The PCR amplification of the target sites were performed 
using primers (forward 5’-ttgacaccaaagcaaatgctcact-3’, reverse 5’-






Figure 2.2 Principle and strategy for integration of mCherry-CAAX into the genome. 
Stepwise cleavage of genome and integration of mCherry construct into the genome. The 
TALEN L and TALEN R bind to the target site, form a FokI dimer, and cleave the spacer 
region, creating a double strand break (DSB). The mCherry-CAAX construct will be 
integrated by homology-directed recombination (HDR). 
 
product was scanned by light scanner (Idaho technology) to determine the melting curve.   
 
2.3    Results 
2.3.1  fabp11a TALEN sites design and assembly 
 FABP belongs to the family of intracellular lipid binding proteins (iLBP) that bind to 
fatty acids in the cells (68). The mammalian Fapb4 (also called adipocyte protein 2 -ap2) 
is a member of the iLBP family that is highly expressed in adipocytes and is considered a 
marker of differentiated adipocytes. The Fabp4 gene is also expressed in macrophages 
and dendritic cells (69). Zebrafish have two homologues of mammalian Fabp4, i.e., 




mature adipocytes (27) and functions in lipid binding and transport. The Fabp4 promoter 
sequence is widely used for adipose tissue specific expression of the transgene in mice. 
Considering these facts, we choose fabp11a as a candidate for inserting the mCherry gene 
cassette at the 3’ end of the gene. We designed the TALEN binds target DNA site near 
the 3’ boundary regions of exon 4 as shown in Fig. 2.3a.  
 
2.3.2  mCherry-CAAX constructs design and assembly 
 We designed a reporter construct that consists of a cDNA that encodes the 
membrane-bound mCherry-CAAX as shown in (Fig. 2.3b). Addition of the CAAX 
prenylation signal at the C-terminus of mCherry tethers mCherry to the plasma 
membrane (71). The membrane localization of the reporter has been shown to enhance 
the signal in adipocytes (49). Immediately upstream of the mCherry sequence, we placed 
the viral 2A peptide coding sequence. When a ribosome encounters a 2A sequence, 
peptide bond formation between a particular glycine and proline fails, resulting in 2 
peptides (72). This permits the expression of the mCherry-CAAX reporter under the 
endogenous fabp11a promoter without disrupting endogenous fabp11a gene expression 
and fabp11a protein function. The flanking homologous arms direct integration of the 
construct during HDR / NHEJ DNA repair of the double-strand break introduced by the 
fabp11a TALEN (Fig. 2.2) (64, 65). The integration of the double stranded construct 
depends on the identity of the homologous arm to the target site and the length of the 








Figure 2.3 Representation of the TALEN binding site, mCherry construct assembly, and 
TALEN activity.  a) Representation of the TALEN binding site on exon 4 of the fabp11a 
gene. b) Represents donor plasmid mCherry-CAAX flanked by homologous arms. c) 
HRMA analysis of fabp11a TALEN mRNA (400 pg) injected embryos. 4/50 injected 







2.3.3  Determination of TALEN activity 
 We injected 100 pg, 200 pg, and 400 pg of TALEN mRNA into one-cell stage 
zebrafish embryos (Fig. 2.3c). If the TALEN creates the double-strand break in the 
predefined region of fabp11a gene, the host recruits and activates the error prone NHEJ 
repair machinery, resulting in mutation in the genome. The induced mutation can be 
analyzed using HRMA. The result suggests that the TALEN activity introducing the 
double strand break in the genome of zebrafish was low even at high concentration 
(400pg) of TALEN RNA.  Most studies have found that the 100 to 200 pg of TALEN is 
sufficient to efficiently create a double-strand break in the genome. 
 
2.4    Discussion 
In principle, the TALEN DNA binding domain can be manipulated to introduce a 
double-strand break at any target site. There are multiple factors that may influence its 
binding and nuclease activity. The TALEN activity depends on the target site complexity, 
amount of TALEN mRNA injected, TALEN binding, and injection to embryos (64). 
Alteration in a single base can reduce the TALEN binding to the target site in the 
genome. We have used genotyped animals that have no mutation at the TALEN binding 
site. Previous studies have revealed that introduction of a double strand break depends on 
the amount of the TALEN mRNA injected into embryos. The literature has reported that 
approximately 100 to 200 pg of TALEN mRNA is needed for an efficient double strand 
break (64, 65). We have increased the concentration to 400 pg of TALEN mRNA. We 
have not obtained an efficient DSB in the target site. So far, there are no tools to predict 




assay have been previously used to determine the DNA binding and nuclease activity of 
TALEN (73). This assay will help us to determine if the fabp11a TALEN we have 
designed is able to bind the target site and introduce a double strand break.  This involves 
the synthesis of a short stretch of target DNA and assay with TALEN protein to 
determine the cleavage of the target DNA in vitro.  
The target complexity is the inherent issue associated with TALEN activity in vivo. 
The chromatin state and DNA methylation site hinder the binding of TALEN to the target 
DNA (60).  Complete evidence on DNA methylation and the chromatin state of fabp11a 
gene during the embryonic stage is not available.  The CRISPR/Cas9 system is alternate 
genome engineering tools that can be utilized to introduce DSB in target site. 
CRISPR/Cas9 system is not sensitive to the methylation state of the genome region 
compared to TALENs (67). Since it is an RNA guided nuclease system, it is simpler to 
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